Study to Evaluate the Safety and Efficacy of KITE-439 in HLA-A*02:01+ Adults With Relapsed/Refractory HPV16+ Cancers

Clinical trial NCT03912831 · TERMINATED

Trial details

NCT number

NCT03912831

Sponsor

Gilead Sciences

Status

TERMINATED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2019-04-30

Primary completion

2022-02-18

Enrollment

8

View on ClinicalTrials.gov